Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. – Cost Effective Supplements

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/2899663

Conclusion of this study

Treatment with feverfew was associated with a reduction in the mean number and severity of attacks in each two-month period, and in the degree of vomiting; duration of individual attacks was unaltered. Visual analogue scores also indicated a significant improvement with feverfew. There were no serious side-effects.